Cargando…

Inhibin Alpha-Subunit (INHA) Expression in Adrenocortical Cancer Is Linked to Genetic and Epigenetic INHA Promoter Variation

Adrenocortical carcinoma (ACC) is a rare, but highly malignant tumor of unknown origin. Inhibin α-subunit (Inha) knockout mice develop ACCs following gonadectomy. In man, INHA expression varies widely within ACC tissues and its circulating peptide inhibin pro-αC has been described as a novel tumor m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofland, Johannes, Steenbergen, Jacobie, Voorsluijs, Jacoba M., Verbiest, Michael M. P. J., de Krijger, Ronald R., Hofland, Leo J., de Herder, Wouter W., Uitterlinden, Andre G., Feelders, Richard A., de Jong, Frank H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128726/ https://www.ncbi.nlm.nih.gov/pubmed/25111790 http://dx.doi.org/10.1371/journal.pone.0104944

Ejemplares similares

ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase
por: Hofland, Johannes, et al.
Publicado: (2013)

The first report on homozygous INHA inactivation in humans
por: Huhtaniemi, Ilpo
Publicado: (2022)

The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures
por: van Koetsveld, Peter M, et al.
Publicado: (2019)

Binding Thermodynamics and Dissociation Kinetics Analysis Uncover the Key Structural Motifs of Phenoxyphenol Derivatives as the Direct InhA Inhibitors and the Hotspot Residues of InhA
por: Zhang, Qianqian, et al.
Publicado: (2022)

Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020)

Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA
por: Xia, Yi, et al.
Publicado: (2018)

Correction to Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors
por: Sabbah, Mohamad, et al.
Publicado: (2020)

Effect of epigenetic treatment on SST(2) expression in neuroendocrine tumour patients
por: Refardt, Julie, et al.
Publicado: (2022)

InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis
por: Flint, Lindsay, et al.
Publicado: (2020)

Association between INHA gene polymorphisms and litter size in Hainan black goats
por: Bian, Zhengyu, et al.
Publicado: (2023)

Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations
por: Cohen, Elisangela ML, et al.
Publicado: (2011)

An Effective Approach for Clustering InhA Molecular Dynamics Trajectory Using Substrate-Binding Cavity Features
por: De Paris, Renata, et al.
Publicado: (2015)

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA
por: Prati, Federica, et al.
Publicado: (2018)

Survey of Potentially Inappropriate Prescription Using STOPP/START Criteria in Inha University Hospital
por: Lee, Sang-Jin, et al.
Publicado: (2013)

Analysis of Expression and Single Nucleotide Polymorphisms of INHA Gene Associated with Reproductive Traits in Chickens
por: Cui, Zhifu, et al.
Publicado: (2019)

Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates
por: Charan, Ashok Singh, et al.
Publicado: (2020)

Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations
por: Wasserman, Sean, et al.
Publicado: (2020)

Association of Polymorphisms in FSHR, INHA, ESR1, and BMP15 with Recurrent Implantation Failure
por: Ko, Eun-Ju, et al.
Publicado: (2023)

In silico study of phytochemicals contained in Brucea javanica in inhibiting the InhA enzyme as antituberculosis
por: Sulistyowaty, Melanny Ika, et al.
Publicado: (2023)

Epigenetic regulation of SST(2) expression in small intestinal neuroendocrine tumors
por: Klomp, Maria J., et al.
Publicado: (2023)

The role of mTOR pathway as target for treatment in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

A selective method for optimizing ensemble docking-based experiments on an InhA Fully-Flexible receptor model
por: De Paris, Renata, et al.
Publicado: (2018)

Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA
por: Kumar, Vivek, et al.
Publicado: (2015)

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor
por: Martínez-Hoyos, María, et al.
Publicado: (2016)

The Value of the inhA Mutation Detection in Predicting Ethionamide Resistance Using Melting Curve Technology
por: Song, Yanhua, et al.
Publicado: (2021)

Correlation of inhA mutations and ethionamide susceptibility: Experience from national reference center for tuberculosis
por: Sarin, Rohit, et al.
Publicado: (2021)

Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug resistant Mycobacterium tuberculosis
por: Harrison, Gregory A., et al.
Publicado: (2023)

How to Differentiate Benign from Malignant Adrenocortical Tumors?
por: Viëtor, Charlotte L., et al.
Publicado: (2021)

Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women
por: Blažević, Anela, et al.
Publicado: (2022)

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
por: Klomp, M.J., et al.
Publicado: (2020)

Peptide Receptor Radionuclide Therapy
por: Hofland, Johannes, et al.
Publicado: (2022)

Bacillus anthracis Protease InhA Increases Blood-Brain Barrier Permeability and Contributes to Cerebral Hemorrhages
por: Mukherjee, Dhritiman V., et al.
Publicado: (2011)

Minor Contribution of inhA-15 Mutations to the Rapid Detection of Isoniazid Resistance in Mycobacterium Tuberculosis Isolates
por: Abkar, Roya, et al.
Publicado: (2016)

Detection of KatG/inhA Mutation to Guide Isoniazid and Ethionamide Use for Drug-resistant Tuberculosis
por: Namburete, Evangelina
Publicado: (2017)

Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme
por: Venugopala, Katharigatta N., et al.
Publicado: (2021)

INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment
por: Zhang, Xun, et al.
Publicado: (2023)

Rescue of bmp15 deficiency in zebrafish by mutation of inha reveals mechanisms of BMP15 regulation of folliculogenesis
por: Zhai, Yue, et al.
Publicado: (2023)

New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis
por: Chetty, Sarentha, et al.
Publicado: (2021)

A Structural and Energetic Model for the Slow-Onset Inhibition of the Mycobacterium tuberculosis Enoyl-ACP Reductase InhA
por: Li, Huei-Jiun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_csjrkkfd03lf2fi4uktt3qekb8